BBP: Virtus LifeSci Biotech Products ETF

BBP新闻

• 17:10 Market Concentration: Building For More Than One Outcome
• 16:40 Equity Outlook: AI, Higher Rates Raise The Bar For Diversification
• 18:25 Where Healthcare Innovation Meets Investment Opportunity
• 15:37 David Rubenstein Of The Carlyle Group On The Business Of Sports, Investing And Leadership
• 16:03 Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
• 16:05 The Market May Be Telling Us We're Entering A Capital Formation Cycle
• 14:55 Where Is Growth?
• 06:45 The Investor Mentality
• 04:10 The Market Is Trying To Tell Us Something About 2027
• 07:18 The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP
• 17:54 BBP: The Biotech ETF That Filters For FDA-Approved Drugs (NYSEARCA:BBP)
• 14:09 Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth
• 01:10 Healthy And Energized At New Highs
• 04:30 Nearly A Third Of Tech Has Raised Guidance
• 04:30 Is The S&P 500's Concentrated Rally Starting To Diversify?
• 05:20 Health Care Shakes Off A 5-Day Slide
• 03:58 Health Care's Clean Bill Of Breadth
• 12:25 Healthcare Systems' Liquidity Challenge
• 07:35 The Steepener Was Built On A Barrel Of Oil
• 05:20 This Week's Market Wrap: AI Shakeup, Earnings, And Renewed Oil Shock
• 12:50 The Next Big Theme: July 2026
• 03:45 Equity Outlook Q3 2026: Broadening Earnings Growth Meets Elevated Volatility
• 15:35 It's Not All About AI: Where To Find Other Potential Market Opportunities
• 06:30 Healthcare Investing: Finding Growth Beyond Pharmaceuticals